ARTICLES BY ESTEL GRACE MASANGKAY
-
Researchers Discover Potential New Treatment Method For ALS12/2/2014
A team of scientists at Thomas Jefferson University reported their discovery of a new approach to help enhance the efficacy of drugs that target Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease.
-
MIT Team Hacks Anthrax To Deliver Cancer Drugs9/29/2014
A team of chemists from the Massachusetts Institute of Technology (MIT) reported that they have turned to bacillus anthracis bacteria, the culprit behind anthrax infection, in order to deliver cancer drugs more effectively.
-
FDA Grants Orphan Status To MabVax’s Neuroblastoma Vaccine9/29/2014
Clinical stage oncology drug development firm MabVax Therapeutics announced that it has received the coveted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its vaccine targeting childhood cancer neuroblastoma.
-
Merck KGaA To Acquire Sigma-Aldrich For $17B9/24/2014
Germany-based Merck KGaA announced that it will acquire St. Louis-based chemical firm Sigma-Aldrich to strengthen its laboratory supplies business.